ALNY

Alnylam Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$318.85

Market Cap

$42.29B

Beta

0.38

P/E

141.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+65.19%

EPS Growth (YoY)+204.15%

Revenue CAGR 3Y+52.98%

P/E Ratio141.4

PEG Ratio0.69

FCF Yield+1.10%

Debt / Equity1.62

Interest Coverage2.0x

No credit card required

Already have an account? Sign in to view the full analysis for ALNY.